Unique Characteristics of Epilepsy Development in Neurocysticercosis.

Brain / diagnostic imaging Calcinosis / diagnostic imaging Cytokines / immunology Epilepsy / etiology Hippocampus / diagnostic imaging Humans Inflammation / immunology Neurocysticercosis / complications Risk Factors Sclerosis

Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 21 5 2020
medline: 11 11 2020
entrez: 21 5 2020
Statut: ppublish

Résumé

The parasitic helminth infection neurocysticercosis (NCC) is the most common cause of adult-acquired epilepsy in the world. Despite the serious consequences of epilepsy due to this infection, an in-depth review of the distinct characteristics of epilepsy due to neurocysticercosis has never been conducted. In this review, we evaluate the relationship between NCC and epilepsy and the unique characteristics of epilepsy caused by NCC. We also discuss recent advances in our understanding of NCC-related epilepsy, including the importance of anti-inflammatory therapies, the association between NCC and temporal lobe epilepsy, and the recent discovery of biomarkers of severe epilepsy development in individuals with NCC and seizures.

Identifiants

DOI: 10.4269/ajtmh.19-0485 PMID: 32431269 PMC: PMC7410468
pubmed: 32431269
doi: 10.4269/ajtmh.19-0485
pmc: PMC7410468
pii: tpmd190485
doi:
pii:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

639-645

Subventions

Organisme : NINDS NIH HHS
ID : R21 NS094976
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI129909
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS086974
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW001140
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116456
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

AJNR Am J Neuroradiol. 1998 Jan;19(1):15-8
pubmed: 9432152
J Neurol Neurosurg Psychiatry. 1992 Apr;55(4):252-4
pubmed: 1583508
Am J Trop Med Hyg. 2014 Feb;90(2):318-21
pubmed: 24394477
Ann Trop Med Parasitol. 2001 Mar;95(2):167-75
pubmed: 11299123
Emerg Infect Dis. 2015 Jun;21(6):969-76
pubmed: 25988221
Epilepsia. 2015 Nov;56(11):1747-52
pubmed: 26513213
Pathog Glob Health. 2012 Sep;106(5):280-5
pubmed: 23265552
Clin Neurol Neurosurg. 1999 Dec;101(4):225-8
pubmed: 10622449
Seizure. 1998 Apr;7(2):153-7
pubmed: 9627207
AJNR Am J Neuroradiol. 1993 May-Jun;14(3):753-62
pubmed: 8517369
Epilepsia. 2014 Sep;55(9):1452-9
pubmed: 25092547
J Clin Neurosci. 2007 Dec;14(12):1172-7
pubmed: 17964789
J Neurol Sci. 2017 May 15;376:1-6
pubmed: 28431589
Epilepsy Res. 2018 Sep;145:145-152
pubmed: 30007239
Neurology. 1992 Feb;42(2):389-92
pubmed: 1736171
Epilepsia. 2000 Mar;41(3):342-51
pubmed: 10714408
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):485-8
pubmed: 16543527
J Neuroimmunol. 2009 Jan 3;206(1-2):118-20
pubmed: 18947884
J Infect Dis. 2010 Oct 15;202(8):1219-25
pubmed: 20807077
Clin Infect Dis. 2018 Jan 6;66(2):282-288
pubmed: 29020381
Epilepsia. 2003 Nov;44(11):1397-401
pubmed: 14636346
Epilepsia. 2005 Apr;46(4):583-7
pubmed: 15816956
Epilepsia. 2017 Nov;58(11):1955-1961
pubmed: 28850668
Epilepsia. 2012 Dec;53(12):2194-202
pubmed: 23148555
Expert Rev Neurother. 2011 Aug;11(8):1175-83
pubmed: 21797658
Epilepsia. 2000 Jun;41(6):718-26
pubmed: 10840405
Epilepsy Curr. 2004 May-Jun;4(3):107-11
pubmed: 16059465
Epilepsia. 2005;46 Suppl 11:18-27
pubmed: 16393174
PLoS Negl Trop Dis. 2016 Feb 05;10(2):e0004418
pubmed: 26849048
Clin Infect Dis. 1999 Nov;29(5):1203-9
pubmed: 10524964
Ann Clin Transl Neurol. 2018 Apr 10;5(5):630-639
pubmed: 29761125
Epilepsia. 2015 Jun;56(6):973-4
pubmed: 26040532
PLoS One. 2015 Jul 01;10(7):e0131180
pubmed: 26132287
Am J Trop Med Hyg. 2011 Sep;85(3):460-3
pubmed: 21896805
Lancet Neurol. 2008 Dec;7(12):1099-105
pubmed: 18986841
J Neurol Sci. 2006 Apr 15;243(1-2):77-81
pubmed: 16430923
Semin Neurol. 2015 Jun;35(3):193-200
pubmed: 26060898
Arq Neuropsiquiatr. 2014 Jul;72(7):510-6
pubmed: 25054983
Epilepsy Behav. 2017 Nov;76:146-150
pubmed: 28526213
Epilepsia. 2010 Jun;51(6):1097-100
pubmed: 20345935
N Engl J Med. 2004 Jan 15;350(3):249-58
pubmed: 14724304
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Epilepsia. 2003;44 Suppl 6:1-88
pubmed: 12919341
Epilepsia. 2007;48 Suppl 2:65-74
pubmed: 17571354
Epilepsia. 2012 Apr;53(4):e60-2
pubmed: 22242912
PLoS Negl Trop Dis. 2010 Feb 02;4(2):e594
pubmed: 20126403
Front Neurol. 2019 Apr 30;10:449
pubmed: 31114540
PLoS One. 2013 Sep 13;8(9):e74052
pubmed: 24058514
Arch Neurol. 1996 Mar;53(3):233-9
pubmed: 8651876
Epilepsy Res. 2015 Oct;116:34-9
pubmed: 26354165
Epilepsy Res. 2017 Nov;137:78-83
pubmed: 28963902
Arch Intern Med. 1990 Feb;150(2):325-7
pubmed: 2302008
Epilepsia. 1996 Mar;37(3):224-9
pubmed: 8598179
Epilepsia. 2001 Apr;42(4):515-24
pubmed: 11440347
Neurology. 2004 Jun 8;62(11):1934-8
pubmed: 15184592
Trans R Soc Trop Med Hyg. 2009 Feb;103(2):144-50
pubmed: 18804830
Clin Infect Dis. 2018 Apr 3;66(8):1159-1163
pubmed: 29617787
Am J Trop Med Hyg. 2019 Mar;100(3):609-616
pubmed: 30608049
PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2692
pubmed: 24551255
Epilepsia. 2013 May;54(5):783-92
pubmed: 23621876
J Clin Gastroenterol. 2001 Oct;33(4):289-94
pubmed: 11588541
Clin Infect Dis. 2001 Nov 15;33(10):1649-53
pubmed: 11595994
Neuroimaging Clin N Am. 2012 Nov;22(4):659-76
pubmed: 23122261
Epilepsy Behav. 2017 Nov;76:151-157
pubmed: 28882721
Am J Trop Med Hyg. 2015 Jan;92(1):64-8
pubmed: 25349375
Epilepsia. 2013 Aug;54 Suppl 4:61-9
pubmed: 23909854
Neuroepidemiology. 2003 Mar-Apr;22(2):139-45
pubmed: 12629280
Am J Trop Med Hyg. 2013 Nov;89(5):919-23
pubmed: 24002482
J Neurosurg. 1996 Apr;84(4):629-33
pubmed: 8613855
Neuropathol Appl Neurobiol. 2014 Aug;40(5):520-43
pubmed: 24762203
PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2558
pubmed: 24244783
Medicine (Baltimore). 2016 Apr;95(17):e3288
pubmed: 27124018
Epilepsy Behav. 2017 Nov;76:158-162
pubmed: 28606690
Epilepsia. 2011 Oct;52(10):1918-27
pubmed: 21777233
Parasitology. 2011 Sep;138(11):1423-8
pubmed: 21813044
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2480
pubmed: 24205415
Int J Infect Dis. 2013 Aug;17(8):e583-92
pubmed: 23339852
Acta Trop. 2003 Jun;87(1):71-8
pubmed: 12781380
Neuroepidemiology. 2009;33(1):25-31
pubmed: 19325247
Epilepsia. 2013 Oct;54(10):1815-22
pubmed: 24032594
Trop Med Int Health. 2015 Apr;20(4):546-52
pubmed: 25581851
Lancet Infect Dis. 2014 Aug;14(8):687-695
pubmed: 24999157
Parasitol Int. 2008 Jun;57(2):166-71
pubmed: 18234551
Neurosciences (Riyadh). 2014 Oct;19(4):317-21
pubmed: 25274593
Epilepsy Curr. 2014 Jan;14(1 Suppl):23-8
pubmed: 24955072
Seizure. 2011 Mar;20(2):119-25
pubmed: 21145263
ScientificWorldJournal. 2012;2012:159821
pubmed: 22312322

Auteurs

Jesica A Herrick (JA)

1Division of Infectious Diseases, Immunology, and International Medicine, University of Illinois at Chicago, Chicago, Illinois.

Javier A Bustos (JA)

2Center for Global Health, Instituto Nacional de Ciencias Neurológicas, Universidad Peruana Cayetano Heredia, and Cysticercosis Unit, Lima, Perú.

Philip Clapham (P)

1Division of Infectious Diseases, Immunology, and International Medicine, University of Illinois at Chicago, Chicago, Illinois.

Hector H Garcia (HH)

2Center for Global Health, Instituto Nacional de Ciencias Neurológicas, Universidad Peruana Cayetano Heredia, and Cysticercosis Unit, Lima, Perú.

Jeffrey A Loeb (JA)

3Department of Neurology and Rehabilitation Medicine, University of Illinois at Chicago, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Maladies métaboliques et nutritionnelles › Maladies métaboliques › Troubles du métabolisme du calcium › Calcinose › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Encéphalopathies › Épilepsie › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Télencéphale › Cerveau › Cortex cérébral › Hippocampe › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Infections du système nerveux central › Infections parasitaires du système nerveux central › Helminthiases du système nerveux central › Neurocysticercose › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Unique Characteristics of Epilepsy Development...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Sclérose › Unique Characteristics of Epilepsy Development...